Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- HPA035180 - Provider product page
- Provider
- Atlas Antibodies
- Proper citation
- Atlas Antibodies Cat#HPA035180, RRID:AB_10669901
- Product name
- Anti-SLC38A2
- Antibody type
- Polyclonal
- Description
- Polyclonal Antibody against Human SLC38A2, Gene description: solute carrier family 38, member 2, Alternative Gene Names: ATA2, KIAA1382, SAT2, SNAT2, Validated applications: IHC, Uniprot ID: Q96QD8, Storage: Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 100 µl
- Concentration
- 0.1 mg/ml
- Storage
- Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Handling
- The antibody solution should be gently mixed before use.
Submitted references ASCT2 is a major contributor to serine uptake in cancer cells
Oncogenic KRAS mutations enhance amino acid uptake by colorectal cancer cells via the hippo signaling effector YAP1
Regulation of Glutamine Carrier Proteins by RNF5 Determines Breast Cancer Response to ER Stress-Inducing Chemotherapies
Conger K, Chidley C, Ozgurses M, Zhao H, Kim Y, Semina S, Burns P, Rawat V, Lietuvninkas L, Sheldon R, Ben-Sahra I, Frasor J, Sorger P, DeNicola G, Coloff J
Cell Reports 2024;43(8):114552
Cell Reports 2024;43(8):114552
Conger K, Chidley C, Ozgurses M, Zhao H, Kim Y, Semina S, Burns P, Rawat V, Sheldon R, Ben-Sahra I, Frasor J, Sorger P, DeNicola G, Coloff J
2023
2023
Oncogenic KRAS mutations enhance amino acid uptake by colorectal cancer cells via the hippo signaling effector YAP1
Kandasamy P, Zlobec I, Nydegger D, Pujol‐Giménez J, Bhardwaj R, Shirasawa S, Tsunoda T, Hediger M
Molecular Oncology 2021;15(10):2782-2800
Molecular Oncology 2021;15(10):2782-2800
Regulation of Glutamine Carrier Proteins by RNF5 Determines Breast Cancer Response to ER Stress-Inducing Chemotherapies
Jeon Y, Khelifa S, Ratnikov B, Scott D, Feng Y, Parisi F, Ruller C, Lau E, Kim H, Brill L, Jiang T, Rimm D, Cardiff R, Mills G, Smith J, Osterman A, Kluger Y, Ronai Z
Cancer Cell 2015;27(3):354-369
Cancer Cell 2015;27(3):354-369
No comments: Submit comment
No validations: Submit validation data